| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.98B | 29.61B | 30.27B | 29.25B | 28.91B | 28.98B |
| Gross Profit | 7.13B | 6.96B | 6.82B | 6.93B | 6.95B | 5.94B |
| EBITDA | 5.78B | 5.56B | 5.53B | 5.55B | 5.73B | 4.91B |
| Net Income | 3.42B | 2.42B | 3.24B | 3.28B | 3.52B | 3.00B |
Balance Sheet | ||||||
| Total Assets | 42.25B | 43.83B | 41.00B | 38.86B | 36.37B | 34.23B |
| Cash, Cash Equivalents and Short-Term Investments | 15.25B | 13.54B | 12.15B | 12.36B | 13.59B | 12.33B |
| Total Debt | 611.72M | 3.33M | 6.55M | 133.28M | 29.10M | 44.47M |
| Total Liabilities | 5.19B | 6.78B | 5.37B | 5.29B | 5.13B | 5.54B |
| Stockholders Equity | 36.94B | 36.94B | 35.52B | 33.46B | 31.14B | 28.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.49B | 1.18B | 16.64M | 2.33B | 2.78B |
| Operating Cash Flow | 0.00 | 3.78B | 3.50B | 4.16B | 3.58B | 3.53B |
| Investing Cash Flow | 0.00 | -1.35B | -2.33B | -4.44B | -1.31B | -697.69M |
| Financing Cash Flow | 0.00 | -1.04B | -1.34B | -1.00B | -1.02B | -891.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.23B | 15.74 | ― | 1.49% | 1.23% | 0.12% | |
74 Outperform | ¥48.85B | 16.07 | ― | 2.58% | 0.76% | -22.12% | |
66 Neutral | ¥69.57B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥40.87B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥18.28B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥6.27B | 19.21 | ― | 2.29% | 0.08% | 105.25% |